These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2458873)

  • 1. Stimulatory effect of CD5 antibody on B cells from patients with rheumatoid arthritis.
    Hara M; Kitani A; Hirose T; Norioka K; Harigai M; Suzuki K; Tabata H; Kawakami M; Kawagoe M; Nakamura H
    Clin Immunol Immunopathol; 1988 Nov; 49(2):223-30. PubMed ID: 2458873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis.
    Hidaka T; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishizuka T; Kawagoe M; Nakamura H
    Clin Exp Immunol; 1992 Aug; 89(2):223-9. PubMed ID: 1379131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional features of CD5+ B lymphocytes in rheumatoid arthritis.
    Plater-Zyberk C; Maini RN
    Scand J Rheumatol Suppl; 1988; 75():76-83. PubMed ID: 2467354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Smith HR; Olson RR
    J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives.
    Youinou P; Mackenzie L; Katsikis P; Merdrignac G; Isenberg DA; Tuaillon N; Lamour A; Le Goff P; Jouquan J; Drogou A
    Arthritis Rheum; 1990 Mar; 33(3):339-48. PubMed ID: 1690541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight IgM and CD5 B lymphocytes in rheumatoid arthritis.
    Xu H; Geddes R; Roberts-Thomson PJ
    Ann Rheum Dis; 1994 Jun; 53(6):383-90. PubMed ID: 7518662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Fetal-type' B and T lymphocytes in rheumatoid arthritis and primary Sjögren's syndrome.
    Plater-Zyberk C; Brennan FM; Feldmann M; Maini RN
    J Autoimmun; 1989 Jun; 2 Suppl():233-41. PubMed ID: 2476142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity.
    Becker H; Weber C; Storch S; Federlin K
    Clin Immunol Immunopathol; 1990 Aug; 56(2):219-25. PubMed ID: 1696188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased numbers of CD5+ B cells and T cell receptor (TCR) gamma delta+ T cells are associated with younger age of onset in rheumatoid arthritis (RA).
    Hassan J; Yanni G; Hegarty V; Feighery C; Bresnihan B; Whelan A
    Clin Exp Immunol; 1996 Mar; 103(3):353-6. PubMed ID: 8608631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD5-positive and CD5-negative rheumatoid factor-secreting B cells in IgA nephropathy, rheumatoid arthritis and Graves' disease.
    Jones BM; Cheng IK; Wong RW; Kung AW
    Scand J Immunol; 1993 Dec; 38(6):575-80. PubMed ID: 7504827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polyclonal activated circulating B-lymphocytes in patients with rheumatoid arthritis].
    Becker H; Weber C; Renelt M; Federlin K
    Z Rheumatol; 1990; 49(1):34-8. PubMed ID: 1691568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoreactive and polyreactive rheumatoid factors produced by in vitro Epstein-Barr virus-transformed peripheral blood and synovial B lymphocytes from rheumatoid arthritis patients.
    Burastero SE; Cutolo M; Dessì V; Celada F
    Scand J Immunol; 1990 Oct; 32(4):347-57. PubMed ID: 1700467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of serum V kappa IIIb light chains in rheumatoid arthritis and correlation with CD5-positive B-cells.
    Smalley HB; Todd J; Barnes RM; Thompson RN; Abraham GN; Johnson PM
    Br J Rheumatol; 1990 Oct; 29(5):325-30. PubMed ID: 1699625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface antigen CD5 is a marker for activated human B cells.
    Werner-Favre C; Vischer TL; Wohlwend D; Zubler RH
    Eur J Immunol; 1989 Jul; 19(7):1209-13. PubMed ID: 2474446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human CD5 (Leu-1, OKT1)+ B lymphocytes and the antibodies they produce.
    Burastero SE; Casali P
    Contrib Microbiol Immunol; 1989; 11():231-62. PubMed ID: 2479500
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between circulating CD5+ B lymphocytes and in vitro autoantibody synthesis in normal individuals.
    Jasin HE
    Cell Immunol; 1991 Aug; 136(1):133-41. PubMed ID: 1711929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD5 positive B cells in peripheral blood and lymph nodes in rheumatoid arthritis.
    Wong SY; Sewell HF
    J Clin Pathol; 1991 Jan; 44(1):85-6. PubMed ID: 1705264
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone resorption correlates with the frequency of CD5⁺ B cells in the blood of patients with rheumatoid arthritis.
    Engelmann R; Wang N; Kneitz C; Müller-Hilke B
    Rheumatology (Oxford); 2015 Mar; 54(3):545-53. PubMed ID: 25193807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in peripheral blood CD5 (Bla) B-cell populations and autoantibodies following blood transfusion.
    Paglieroni TG; Ward J; Holland PV
    Transfusion; 1995 Mar; 35(3):189-98. PubMed ID: 7533341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study of circulating CD5 positive B lymphocytes in Chinese patients with rheumatoid arthritis.
    Liu ST; Wang CR; Liu MF; Li JS; Lei HY; Chuang CY
    Clin Rheumatol; 1996 May; 15(3):250-3. PubMed ID: 8793255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.